Novocure Announces Preliminary Full Year and Fourth Quarter 2023 Net Revenues and Provides Company Update : vimarsana.com

Preliminary full year 2023 net revenues of $509 million and fourth quarter net revenues of $134 million


PMA application for TTFields in NSCLC submitted for review to U.S. Food and Drug...

Related Keywords

United States , New Hampshire , Japan , Germany , China , Switzerland , Tokyo , France , Israel , Japanese , Optune Gio , Nicolas Leupin , William Doyle , Japanese Pharmaceuticals , Twitter , Zai Lab , Devices Agency , Exchange Commission , Tumor Treating Fields , Greater China , Premarket Approval , Medical Devices Agency , Chief Medical , Investor Relations , Tumor Treating , Annual Report , Private Securities Litigation Reform Act , Markets ,